Venous thrombosis: Issues for the pediatrician

Food Insecurity and the Dangers of Infant Formula Dilution

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.

January 30th 2023

FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency

Morgan Ebert, Managing Editor

Demystifying Infant Formula

The FDA accepted Eton Pharmaceuticals' NDA for ET-600 for pediatric arginine vasopressin deficiency, with a target action date in February of 2026.

October 11th 2022

AAP, other medical societies sue HHS, Robert F. Kennedy Jr. over vaccine practices

AAP, other medical societies sue HHS, Robert F. Kennedy Jr. over vaccine advices | Image Credit: © Rafael Henrique - © Rafael Henrique - stock.adobe.com.

FDA approves sebetralstat as first and only on-demand treatment for HAE

Six medical societies, including the American Academy of Pediatrics, are suing the HHS and its Secretary to "defend vaccine policy."

Can you diagnose this 11-year-old with a petechial rash?

Though the original target action date was not met by the FDA, KalVista's sebetralstat is now approved to treat HAE in patients 12 years and older.

Related Content

Drashti Patel, BS, BA;Jyoti Budania, MD

Food Insecurity and the Dangers of Infant Formula Dilution

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.

January 30th 2023

FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency

Morgan Ebert, Managing Editor

Demystifying Infant Formula

The FDA accepted Eton Pharmaceuticals' NDA for ET-600 for pediatric arginine vasopressin deficiency, with a target action date in February of 2026.

October 11th 2022

AAP, other medical societies sue HHS, Robert F. Kennedy Jr. over vaccine practices

FDA approves sebetralstat as first and only on-demand treatment for HAE

Six medical societies, including the American Academy of Pediatrics, are suing the HHS and its Secretary to "defend vaccine policy."